Mr Bruce Pritchard FRSE
Chief Executive Officer, Liminal Biosciences
Bruce Pritchard is CEO of Liminal BioSciences Inc, a biotechnology company that specialises in discovering, developing and commercializing novel, small molecule compounds for metabolic, inflammatory and fibrotic diseases. His career in Life Sciences spans 30 years.
Bruce is a graduate of Heriot-Watt University, a member of the Institute of Chartered Accountants of Scotland (ICAS) and a Fellow of the Institute of Directors. He is also Chair of Court at Heriot-Watt University, Chair of the Audit Committee at the Rosalind Franklin Institute, Chair of the Committee of Scottish University Chairs, a trustee of The Committee of University Chairs and is a Past President ICAS.
